Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 3.4.23.3 - gastricsin and Organism(s) Homo sapiens and UniProt Accession P20142

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Achlorhydria
Gastric emptying and first-pass metabolism of ethanol in elderly subjects with and without atrophic gastritis.
Low acid output in Pima Indians. A possible cause for the rarity of duodenal ulcer in this population.
Acquired Immunodeficiency Syndrome
Serum pepsinogen and gastrin levels in HIV-positive patients: relationship with CD4+ cell count and Helicobacter pylori infection.
Adenocarcinoma
Differentiation towards gastric foveolar, mucopeptic and intestinal goblet cells in gallbladder adenocarcinomas.
Expression of pepsinogen II with androgen and estrogen receptors in human prostate carcinoma.
HELICOBACTER PYLORI CHRONIC GASTRITIS ON PATIENTS WITH PREMALIGNANT CONDITIONS: OLGA AND OLGIM EVALUATION AND SERUM BIOMARKERS PERFORMANCE.
Histogenetical investigations on adenocarcinomas of the esophagogastric junction. An immunohistochemical study.
Identification of primary tumour site by immunolocalization of progastricsin in metastatic adenocarcinoma.
The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis.
[The relationship between concentrations of pepsinogens in blood serum and pathohystologic parameters of stomach adenomas and adenocarcinomas].
Adenoma
[The relationship between concentrations of pepsinogens in blood serum and pathohystologic parameters of stomach adenomas and adenocarcinomas].
Anemia
Fundic atrophic gastritis in an elderly population. Effect on hemoglobin and several serum nutritional indicators.
Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia.
Anemia, Pernicious
Pepsinogens A and C: purification from human gastric mucosa and determination in serum by optimized radioimmunoassays.
Pepsinogens I and II: purification from gastric mucosa and radioimmunoassay in serum.
Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia.
Serum and gastric mucosal pepsinogens in atrophic gastritis, particularly in type A gastritis associated with pernicious anemia in Japanese.
Arthritis, Juvenile
[METHOD FOR DETERMINING EROSIVE LESIONS OF THE GASTRIC MUCOUSA IN CHILDREN WITH JUVENILE ARTHRITIS].
Aspermia
The concentration of pepsinogen C in human semen and the physiological activation of zymogen in the vagina.
Barrett Esophagus
Gastric proteases in Barrett's esophagus.
Histogenetical investigations on adenocarcinomas of the esophagogastric junction. An immunohistochemical study.
Pepsinogen C: a possible biological marker of epithelial differentiation in Barrett's esophagus.
Breast Cyst
Immunofluorometric assay of pepsinogen C and preliminary clinical applications.
Quantification of pepsinogen C and prostaglandin D synthase in breast cyst fluid and their potential utility for cyst type classification.
Breast Diseases
Expression of pepsinogen C in gynecomastias and male breast carcinomas.
Immunofluorometric assay of pepsinogen C and preliminary clinical applications.
Isolation and characterization of a pepsin C zymogen produced by human breast tissues.
Breast Neoplasms
Clinical significance of pepsinogen C tumor expression in patients with stage D2 prostate carcinoma.
Expression and clinical significance of pepsinogen C in epithelial ovarian carcinomas.
Expression and clinical significance of pepsinogen C in resectable pancreatic cancer.
Expression of pepsinogen C in gynecomastias and male breast carcinomas.
Expression of pepsinogen C in human breast tumours and correlation with clinicopathologic parameters.
Hormonal regulation of the human pepsinogen C gene in breast cancer cells. Identification of a cis-acting element mediating its induction by androgens, glucocorticoids, and progesterone.
Immunoenzymatically determined pepsinogen C concentration in breast tumor cytosols: an independent favorable prognostic factor in node-positive patients.
Immunofluorometric assay of pepsinogen C and preliminary clinical applications.
Immunohistochemical study of pepsinogen C expression in cutaneous malignant melanoma: association with clinicopathological parameters.
Overall survival in women with breast cancer: the influence of pepsinogen C gene polymorphism.
Pepsinogen C expression in tumors of extragastric origin.
Pepsinogen C is a new prognostic marker in primary breast cancer.
Breast Neoplasms, Male
Expression of pepsinogen C in gynecomastias and male breast carcinomas.
Carcinogenesis
PGC TagSNP and its interaction with H. pylori and relation with gene expression in susceptibility to gastric carcinogenesis.
Polymorphic rs9471643 and rs6458238 upregulate PGC transcription and protein expression in overdominant or dominant models.
Carcinoma
Clinical significance of pepsinogen C tumor expression in patients with stage D2 prostate carcinoma.
Expression and clinical significance of pepsinogen C in epithelial ovarian carcinomas.
Expression and clinical significance of pepsinogen C in resectable pancreatic cancer.
Expression and prognostic significance of pepsinogen C in gastric carcinoma.
Expression of pepsinogen II with androgen and estrogen receptors in human prostate carcinoma.
Expression of two androgen-induced proteins (pepsinogen C and apolipoprotein d) in epithelial skin cancers of the eyelids.
Gastric atrophy and oesophageal squamous cell carcinoma: possible interaction with dental health and oral hygiene habit.
Histogenetical investigations on adenocarcinomas of the esophagogastric junction. An immunohistochemical study.
Immunofluorometric assay of pepsinogen C and preliminary clinical applications.
Immunolocalisation of aspartic proteinases in the developing human stomach.
Pepsinogen C expression in tumors of extragastric origin.
Pepsinogens I and II in gastric cancer: an immunohistochemical study using monoclonal antibodies.
Role of Serum Pepsinogen I and II Ratio in Screening of Gastric Carcinoma.
Serum pepsinogen as a new marker for gastric carcinoma among young adults. Research Group on Prevention of Gastric Carcinoma among Young Adults.
Serum pepsinogen I and II levels in various gastric disorders with special reference to their use as a screening test for carcinoma stomach.
Tissue and serum pepsinogen I and II in gastric cancer identified using immunohistochemistry and rapid ELISA.
[An immunohistochemical study of pepsinogen type C in the gastric mucosa and in stomach cancer]
[Immunohistochemical demonstration of pepsinogens I and II in the gallbladder]
[Immunohistologic detection of pepsin and gastricsin in carcinoma of the stomach]
Carcinoma, Ductal
Expression of androgen receptor and two androgen-induced proteins (apolipoprotein D and pepsinogen C) in ductal carcinoma in situ of the breast.
Expression of pepsinogen C in gynecomastias and male breast carcinomas.
Carcinoma, Hepatocellular
Overexpressed pepsinogen C is associated with poor prognosis in human hepatocellular carcinoma: a tissue microarray study.
Carcinoma, Intraductal, Noninfiltrating
Expression of androgen receptor and two androgen-induced proteins (apolipoprotein D and pepsinogen C) in ductal carcinoma in situ of the breast.
Carcinoma, Ovarian Epithelial
Expression and clinical significance of pepsinogen C in epithelial ovarian carcinomas.
Carcinoma, Squamous Cell
Expression of two androgen-induced proteins (pepsinogen C and apolipoprotein d) in epithelial skin cancers of the eyelids.
Cysts
Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts.
Quantification of pepsinogen C and prostaglandin D synthase in breast cyst fluid and their potential utility for cyst type classification.
Dehydration
Effects of long-term dehydration on oxidative stress, apoptotic markers and neuropeptides in the gastric mucosa of the dromedary camel.
Diabetes Mellitus
Hypergastrinemia in obese noninsulin-dependent diabetes: a possible reflection of high prevalence of vagal dysfunction.
Duodenal Ulcer
Changes in gastrin and serum pepsinogens in monitoring of Helicobacter pylori response to therapy.
Different effects of H. pylori water extracts on cytokines, pepsinogen C and gastrin mucosal release in patients with or without duodenal ulcer.
Effect of intermittent administration of omeprazole on serum pepsinogens in duodenal ulcer patients and healthy volunteers.
Effect of proximal gastric vagotomy on serum pepsinogen I and II concentrations and acid secretion in duodenal ulcer patients.
Elevated serum pepsinogen I and II levels differ as risk factors for duodenal ulcer and gastric ulcer.
Enzyme-linked immunosorbent assays for serum pepsinogens I and II using monoclonal antibodies--with data on peptic ulcer and gastric cancer.
Genetic heterogeneity of combined gastric and duodenal ulcers detected by pepsinogen C gene polymorphism.
Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
Pepsinogens, pepsins, and peptic ulcer.
Seroepidemiology of gastritis in Japanese and Dutch male employees with and without ulcer disease.
Serum pepsinogen I and pepsinogen II, and the ratio of pepsinogen I/pepsinogen II in peptic ulcer diseases: with special emphasis on the influence of the location of the ulcer crater.
[Is measurement of basal levels of serum pepsinogen II useful in proving the eradication of Helicobacter pylori by treatment?]
Endocrine System Diseases
[Clinico-morphologic criteria for prognosis of stomach cancer]
Esophageal Squamous Cell Carcinoma
Gastric atrophy and oesophageal squamous cell carcinoma: possible interaction with dental health and oral hygiene habit.
Gallbladder Neoplasms
[Immunohistochemical demonstration of pepsinogens I and II in the gallbladder]
Gallstones
Helicobacter pylori infection is positively associated with gallstones: a large-scale cross-sectional study in Japan.
Gastritis
Altered mucosal DNA methylation in parallel with highly active Helicobacter pylori-related gastritis.
Clinical implications of serum pepsinogen and progastricsin in man.
Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers.
Development of gastric cancer and its prevention.
HELICOBACTER PYLORI CHRONIC GASTRITIS ON PATIENTS WITH PREMALIGNANT CONDITIONS: OLGA AND OLGIM EVALUATION AND SERUM BIOMARKERS PERFORMANCE.
Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication.
Helicobacter pylori: prevalence, transmission, and serum pepsinogen II concentrations in children of a poor periurban community in Bangladesh.
Increased Serum Pepsinogen II Level as a Marker of Pangastritis and Corpus-Predominant Gastritis in Gastric Cancer Prevention.
Low acid output in Pima Indians. A possible cause for the rarity of duodenal ulcer in this population.
Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics.
Seroepidemiology of gastritis in Japanese and Dutch male employees with and without ulcer disease.
Seroepidemiology of gastritis in Japanese and Dutch working populations: evidence for the development of atrophic gastritis that is not related to Helicobacter pylori.
Serological parameters in assessment of degree of gastritis in healthy volunteers.
Serum and gastric mucosal pepsinogens in atrophic gastritis, particularly in type A gastritis associated with pernicious anemia in Japanese.
Serum levels of pepsinogen I, pepsinogen II, and gastrin-17 in the course of Helicobacter pylori gastritis in pediatrics.
Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
Serum pepsinogens as markers of response to therapy for Helicobacter pylori gastritis.
Serum pepsinogens I and II and gastric mucosal histology after partial gastrectomy.
Using serum pepsinogens wisely in a clinical practice.
Validity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma.
[Basal concentrations of gastrin and pepsinogen I and II in gastric ulcer: influence of Helicobacter pylori infection and usefulness in the control of the eradication]
[Potentialities of a serological method in diagnosis of atrophic gastritis]
[Serum pepsinogen response to therapy for Helicobacter pylori associated gastro-duodenal disease]
Gastritis, Atrophic
Accuracy of pepsinogens for early diagnosis of atrophic gastritis and gastric cancer in Iranian population.
Effects of polyunsaturated fatty acids on atrophic gastritis in a Japanese population.
Free and protein-bound cobalamin absorption in healthy middle-aged and older subjects.
Fundic atrophic gastritis in an elderly population. Effect on hemoglobin and several serum nutritional indicators.
Gastric emptying and first-pass metabolism of ethanol in elderly subjects with and without atrophic gastritis.
Helicobacter pylori, pepsinogens and gastrin: relationship with age and development of atrophic gastritis.
Influence of laboratory-related and endoscopy-related factors on the assessment of serum pepsinogens and gastrin-17.
Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
Relationship between serologically diagnosed chronic atrophic gastritis, Helicobacter pylori, and environmental factors in Japanese men.
Serum anti-Helicobacter pylori IgG antibodies and pepsinogens A and C as serological markers of chronic atrophic gastritis.
Serum gastrin 17, pepsinogen I and pepsinogen II in atrophic gastritis patients living in North-East of Iran.
Serum pepsinogens I and II and gastric mucosal histology after partial gastrectomy.
The effect of Helicobacter pylori eradication therapy on dyspepsia symptoms in industrial workers in Japan.
The interaction effects of pri-let-7a-1 rs10739971 with PGC and ERCC6 gene polymorphisms in gastric cancer and atrophic gastritis.
The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis.
The Risk of Helicobacter Pylori Infection and Atrophic Gastritis from Food and Drink Intake: a Cross-sectional Study in Hokkaido, Japan.
Gastrointestinal Diseases
Ultrasensitive detection of pepsinogen I and pepsinogen II by a time-resolved fluoroimmunoassay and its preliminary clinical applications.
Gynecomastia
Expression of pepsinogen C in gynecomastias and male breast carcinomas.
Infections
A retrospective study assessing the acceleration effect of type I Helicobacter pylori infection on the progress of atrophic gastritis.
Association between abnormal gastric function risk and Helicobacter pylori infection assessed by ELISA and 14C-urea breath test.
Association between genetic polymorphism of the pepsinogen C gene and gastric body ulcer: the genetic predisposition is not associated with Helicobacter pylori infection.
Associations of Serum Pepsinogens and Helicobacter Pylori Infection with High-Sensitivity C-Reactive Protein in Medical Examination Population.
Changes in gastrin and serum pepsinogens in monitoring of Helicobacter pylori response to therapy.
Changes in serum pepsinogen, gastrin, and immunoglobulin G antibody titers in helicobacter pylori-positive gastric ulcer after eradication of infection.
Clinical implications of serum pepsinogen and progastricsin in man.
Clinical usefulness of serum pepsinogen II in the management of Helicobacter pylori infection.
Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers.
Differences in the levels of gastric cancer risk factors between Nanjing and Minqing counties, China.
Dynamic expression of pepsinogen C in gastric cancer, precancerous lesions and Helicobacter pylori associated gastric diseases.
Endoscopic gastritis, serum pepsinogen assay, and Helicobacter pylori infection.
Functional Dyspesia.
Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication.
Helicobacter pylori infection is markedly increased in patients with autoimmune atrophic thyroiditis.
Helicobacter pylori infection is positively associated with gallstones: a large-scale cross-sectional study in Japan.
Helicobacter pylori serology in patients with chronic gastritis.
Helicobacter pylori, clinical, laboratory, and noninvasive biomarkers suggestive of gastric damage in healthy school-aged children: A case-control study.
Helicobacter pylori, pepsinogens and gastrin: relationship with age and development of atrophic gastritis.
Increased Serum Pepsinogen II Level as a Marker of Pangastritis and Corpus-Predominant Gastritis in Gastric Cancer Prevention.
Influences of Helicobacter pylori on serum pepsinogen concentrations in dialysis patients.
Pepsinogen testing for evaluation of the success of Helicobacter pylori eradication at 4 weeks after completion of therapy.
Pepsinogens and Gastrin Demonstrate Low Discrimination for Gastric Precancerous Lesions in a Multi-Ethnic United States Cohort.
Percentage changes in serum pepsinogens are useful as indices of eradication of Helicobacter pylori.
Relationship between serologically diagnosed chronic atrophic gastritis, Helicobacter pylori, and environmental factors in Japanese men.
Serum pepsinogen and gastrin levels in HIV-positive patients: relationship with CD4+ cell count and Helicobacter pylori infection.
Serum pepsinogen II levels are doubled with Helicobacter pylori infection in an asymptomatic population of 40,383 Chinese subjects.
Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations.
The Risk of Helicobacter Pylori Infection and Atrophic Gastritis from Food and Drink Intake: a Cross-sectional Study in Hokkaido, Japan.
The Validity of a Biomarker Method for Indirect Detection of Gastric Mucosal Atrophy Versus Standard Histopathology.
[Interaction between an insertion/deletion polymorphism in pepsinogen C and Helicobacter pylori infection in the development of gastric cancer]
[Seroepidemiological study on Helicobactor pylori infection in rural adult residents]
Infertility, Male
The concentration of pepsinogen C in human semen and the physiological activation of zymogen in the vagina.
Lymphatic Metastasis
Expression of pepsinogen II in gastric cancer. Its relationship to local invasion and lymph node metastases.
Identification of primary tumour site by immunolocalization of progastricsin in metastatic adenocarcinoma.
Melanoma
Expression and clinical significance of pepsinogen C in uveal melanomas.
Immunohistochemical study of pepsinogen C expression in cutaneous malignant melanoma: association with clinicopathological parameters.
Pepsinogen C expression in tumors of extragastric origin.
Neoplasm Metastasis
Expression of pepsinogen II in gastric cancer. Its relationship to local invasion and lymph node metastases.
Identification of primary tumour site by immunolocalization of progastricsin in metastatic adenocarcinoma.
[Immunohistochemical demonstration of pepsinogens I and II in the gallbladder]
[Immunohistologic detection of pepsin and gastricsin in carcinoma of the stomach]
Neoplasms
A case of intraductal papillary mucinous neoplasm with high serum pepsinogen II level.
Biological variations of seven tumor markers.
Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males.
Characterization of pepsinogen C as a potential biomarker for gastric cancer using a histo-proteomic approach.
Clinical implications of serum pepsinogen and progastricsin in man.
Clinical significance of pepsinogen C tumor expression in patients with stage D2 prostate carcinoma.
Correlation between negative expression of pepsinogen C and a series of phenotypic markers of gastric cancer in different gastric diseases.
Correlations of gastrointestinal hormones with inflammation and intestinal flora in patients with gastric cancer.
Ductal cancers of the pancreas frequently express markers of gastrointestinal epithelial cells.
Expression and clinical significance of pepsinogen C in uveal melanomas.
Expression and prognostic significance of pepsinogen C in gastric carcinoma.
Expression of pepsinogen C in gynecomastias and male breast carcinomas.
Expression of pepsinogen C in human breast tumours and correlation with clinicopathologic parameters.
Expression of pepsinogen II in gastric cancer. Its relationship to local invasion and lymph node metastases.
Identification of primary tumour site by immunolocalization of progastricsin in metastatic adenocarcinoma.
Intraductal tubular adenoma of the pancreas, pyloric gland type: a clinicopathologic and immunohistochemical study of 6 cases.
Marked decrease in serum pepsinogen II levels resulting from endoscopic resection of a large duodenal tumor.
Microcarcinoma in the prostate: its association with duct-acinar dysplasia.
Overexpressed pepsinogen C is associated with poor prognosis in human hepatocellular carcinoma: a tissue microarray study.
Pepsinogen A/pepsinogen C or pepsinogen A multiplied by gastrin in the diagnosis of gastric cancer?
Pepsinogen C expression in tumors of extragastric origin.
Pepsinogen C expression, regulation and its relationship with cancer.
Pepsinogen C is a new prognostic marker in primary breast cancer.
Pepsinogens I and II in carcinoma of the stomach: an immunohistochemical study.
pS2 protein in gastric carcinoma and normal gastric mucosa: association with clincopathological parameters and patient survival.
Searching for New Biomarkers and the Use of Multivariate Analysis in Gastric Cancer Diagnostics.
Seroepidemiology of gastritis in Japanese and Dutch working populations: evidence for the development of atrophic gastritis that is not related to Helicobacter pylori.
The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis.
[Clinico-morphologic criteria for prognosis of stomach cancer]
[Immunohistologic detection of pepsin and gastricsin in carcinoma of the stomach]
[Immunomorphologic study of pepsinogens in stomach cancer]
[The relationship between concentrations of pepsinogens in blood serum and pathohystologic parameters of stomach adenomas and adenocarcinomas].
Neuroendocrine Tumors
Gastric secretion.
Nevus, Pigmented
Immunohistochemical study of pepsinogen C expression in cutaneous malignant melanoma: association with clinicopathological parameters.
Overweight
Only serum pepsinogen I and pepsinogen I/II ratio are specific and sensitive biomarkers for screening of gastric cancer.
Pancreatic Cyst
Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts.
Pancreatic Neoplasms
Expression and clinical significance of pepsinogen C in resectable pancreatic cancer.
Peptic Ulcer
Association between genetic polymorphism of the pepsinogen C gene and gastric body ulcer: the genetic predisposition is not associated with Helicobacter pylori infection.
Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication.
Percentage changes in serum pepsinogens are useful as indices of eradication of Helicobacter pylori.
Prospective study of the effect of gastrectomy with and without bile reflux on serum pepsinogens.
Serum pepsinogen I and pepsinogen II, and the ratio of pepsinogen I/pepsinogen II in peptic ulcer diseases: with special emphasis on the influence of the location of the ulcer crater.
The association of smoking and drinking habits with serum pepsinogens.
[Pepsin and gastricsin secretion in the course of digestion in peptic ulcer and in health]
Persistent Infection
Helicobacter pylori, clinical, laboratory, and noninvasive biomarkers suggestive of gastric damage in healthy school-aged children: A case-control study.
Precancerous Conditions
Impact of pepsinogen C polymorphism on individual susceptibility to gastric cancer and its precancerous conditions in a Northeast Chinese population.
PGC-MG7 combination could be used as a follow-up panel for monitoring dynamical progression of gastric precancerous diseases.
Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
Prostatic Hyperplasia
The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis.
Prostatic Neoplasms
Clinical significance of pepsinogen C tumor expression in patients with stage D2 prostate carcinoma.
Immunofluorometric assay of pepsinogen C and preliminary clinical applications.
The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis.
Renal Insufficiency, Chronic
Renal handling of pepsinogens A and C in man.
Starvation
Regulation of progastricsin mRNA levels in sea bass (Dicentrarchus labrax) in response to fluctuations in food availability.
Spontaneous pepsin C-catalyzed activation of human pepsinogen C in transgenic rice cell suspension culture: Production and characterization of human pepsin C.
Stomach Diseases
Clinical implications of serum pepsinogen and progastricsin in man.
Clinical significance in combined detection of serum pepsinogen I, pepsinogen II and carbohydrate antigen 242 in gastric cancer.
Correlation between negative expression of pepsinogen C and a series of phenotypic markers of gastric cancer in different gastric diseases.
Dynamic expression of pepsinogen C in gastric cancer, precancerous lesions and Helicobacter pylori associated gastric diseases.
LncRNAs adjacent to pepsinogen C in gastric diseases and diagnostic efficiencies of joint detection in gastric diseases.
Stomach Neoplasms
Accuracy of pepsinogens for early diagnosis of atrophic gastritis and gastric cancer in Iranian population.
Association between pepsinogen C gene polymorphism and genetic predisposition to gastric cancer.
Association of Polymorphisms in three pri-miRNAs that Target Pepsinogen C with the Risk and Prognosis of Gastric Cancer.
Characterization of pepsinogen C as a potential biomarker for gastric cancer using a histo-proteomic approach.
Clinical implications of serum pepsinogen and progastricsin in man.
Clinical significance in combined detection of serum pepsinogen I, pepsinogen II and carbohydrate antigen 242 in gastric cancer.
Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels.
Correlation between negative expression of pepsinogen C and a series of phenotypic markers of gastric cancer in different gastric diseases.
Correlation between the prevalence of gastritis and gastric cancer in Japan.
Correlations of gastrointestinal hormones with inflammation and intestinal flora in patients with gastric cancer.
Development of gastric cancer and its prevention.
Diagnostic value of serum pepsinogen I, pepsinogen II, and gastrin-17 levels for population-based screening for early-stage gastric cancer.
Dynamic expression of pepsinogen C in gastric cancer, precancerous lesions and Helicobacter pylori associated gastric diseases.
Endoscopic gastritis, serum pepsinogen assay, and Helicobacter pylori infection.
Enzyme-linked immunosorbent assays for serum pepsinogens I and II using monoclonal antibodies--with data on peptic ulcer and gastric cancer.
Expression and prognostic significance of pepsinogen C in gastric carcinoma.
Expression of pepsinogen II in gastric cancer. Its relationship to local invasion and lymph node metastases.
Expression of serum let-7c, let-7i, and let-7f microRNA with its target gene, pepsinogen C, in gastric cancer and precancerous disease.
Gastric cancer in a Caucasian population: role of pepsinogen C genetic variants.
Impact of pepsinogen C polymorphism on individual susceptibility to gastric cancer and its precancerous conditions in a Northeast Chinese population.
Increased Serum Pepsinogen II Level as a Marker of Pangastritis and Corpus-Predominant Gastritis in Gastric Cancer Prevention.
Pepsinogen A/pepsinogen C or pepsinogen A multiplied by gastrin in the diagnosis of gastric cancer?
Pepsinogen C expression-related lncRNA/circRNA/mRNA profile and its co-mediated ceRNA network in gastric cancer.
Pepsinogen. Prolate ellipsoid or unrecognized pathogen?
Pepsinogens and Gastrin Demonstrate Low Discrimination for Gastric Precancerous Lesions in a Multi-Ethnic United States Cohort.
Pepsinogens I and II in gastric cancer: an immunohistochemical study using monoclonal antibodies.
PGC-MG7 combination could be used as a follow-up panel for monitoring dynamical progression of gastric precancerous diseases.
Polymorphisms in Pepsinogen C and miRNA Genes Associate with High Serum Pepsinogen II in Gastric Cancer Patients.
Prediction of the 10-year probability of gastric cancer occurrence in the Japanese population: the JPHC study cohort II.
RAB26 and RAB3D are direct transcriptional targets of MIST1 that regulate exocrine granule maturation.
Role of Serum Pepsinogen II and Helicobacter pylori Status in the Detection of Diffuse-Type Early Gastric Cancer in Young Individuals in South Korea.
Serum gastrin 17, pepsinogen I and pepsinogen II in atrophic gastritis patients living in North-East of Iran.
Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
Serum pepsinogen II is a better diagnostic marker in gastric cancer.
The interaction effects of pri-let-7a-1 rs10739971 with PGC and ERCC6 gene polymorphisms in gastric cancer and atrophic gastritis.
[Correlation between an insertion-deletion polymorphism in the pepsinogen C gene and gastric cancer as well as its precursors]
[Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects]
[Distribution of serum pepsinogen I, II values and their ratios in residents of a rural area]
[Expression of pepsinogen C in gastric cancer and its precursor]
[Interaction between an insertion/deletion polymorphism in pepsinogen C and Helicobacter pylori infection in the development of gastric cancer]
[Risk of gastric cancer dependent on serological markers of atrophic gastritis: cohort study].
Stomach Ulcer
Elevated serum pepsinogen I and II levels differ as risk factors for duodenal ulcer and gastric ulcer.
Enzyme-linked immunosorbent assays for serum pepsinogens I and II using monoclonal antibodies--with data on peptic ulcer and gastric cancer.
Genetic heterogeneity of combined gastric and duodenal ulcers detected by pepsinogen C gene polymorphism.
Pepsinogen C gene polymorphisms associated with gastric body ulcer.
Pepsinogens, pepsins, and peptic ulcer.
Serum pepsinogen I and pepsinogen II, and the ratio of pepsinogen I/pepsinogen II in peptic ulcer diseases: with special emphasis on the influence of the location of the ulcer crater.
The expression of pepsinogen c mRNA in normal gastroduodenal mucosa and the gastric ulcer margin of the rat.
[Basal concentrations of gastrin and pepsinogen I and II in gastric ulcer: influence of Helicobacter pylori infection and usefulness in the control of the eradication]
Vitamin B 12 Deficiency
Fundic atrophic gastritis in an elderly population. Effect on hemoglobin and several serum nutritional indicators.